Press Releases :: VolitionRx Ltd (VNRX)

Jun 27, 2024 8:00 am EDT

VolitionRx Limited Issues Mid-Year Review Ahead of 2024 Annual Meeting

May 29, 2024 8:00 am EDT

VolitionRx Limited to Present at Jefferies Global Healthcare Conference

May 13, 2024 4:10 pm EDT

VolitionRx Limited Announces First Quarter 2024 Financial Results and Business Update

May 8, 2024 8:00 am EDT

VolitionRx Limited Schedules First Quarter 2024 Earnings Conference Call and Business Update

Apr 23, 2024 8:00 am EDT

Nu.Q® Vet Cancer Test launched in-clinic in U.S. and Europe through Antech

Mar 25, 2024 4:10 pm EDT

VolitionRx Limited Announces Full Fiscal Year 2023 Financial Results and Business Update

Mar 21, 2024 8:30 am EDT

VolitionRx Limited Schedules Fourth Quarter and Full Year 2023 Earnings Conference Call and Business Update

Mar 20, 2024 8:30 am EDT

Volition and Fujifilm Vet Systems Launch Nu.Q® Vet Cancer Test in Japan

Mar 19, 2024 4:30 pm EDT

Volition appoints Dr Andrew Retter as Chief Medical Officer

Feb 2, 2024 8:00 am EST

Volition to Share Nu.Q® NETs Strategy Update at Upcoming Webinar

rss_feed News RSS